These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 32054078)
21. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR. Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125 [TBL] [Abstract][Full Text] [Related]
22. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease. Qattan A Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs in cutaneous melanoma: clinical perspectives. Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644 [TBL] [Abstract][Full Text] [Related]
24. Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma. Ruggiero CF; Fattore L; Terrenato I; Sperati F; Salvati V; Madonna G; Capone M; Valenti F; Di Martino S; Mandoj C; Liguoro D; Castaldo V; Cafaro G; Simeone E; Vanella V; Russillo M; Conti L; Cuda G; Giannarelli D; Ascierto PA; Mancini R; Ciliberto G Theranostics; 2022; 12(17):7420-7430. PubMed ID: 36438490 [No Abstract] [Full Text] [Related]
26. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution? Tamas T; Baciut M; Nutu A; Bran S; Armencea G; Stoia S; Manea A; Crisan L; Opris H; Onisor F; Baciut G; Crisan B; Opris D; Bumbu B; Tamas A; Dinu C Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946878 [TBL] [Abstract][Full Text] [Related]
27. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma. Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117 [TBL] [Abstract][Full Text] [Related]
28. Epigenetics of melanoma: implications for immune-based therapies. Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079 [TBL] [Abstract][Full Text] [Related]
29. Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression. Mannavola F; D'Oronzo S; Cives M; Stucci LS; Ranieri G; Silvestris F; Tucci M Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861757 [TBL] [Abstract][Full Text] [Related]
30. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Shi T; Morishita A; Kobara H; Masaki T Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971 [TBL] [Abstract][Full Text] [Related]
32. A New Approach to Melanoma Treatment: microRNAs. Ilhan S; Oguz F; Atmaca H Curr Top Med Chem; 2024; 24(16):1362-1376. PubMed ID: 38676490 [TBL] [Abstract][Full Text] [Related]
33. Melanoma: Where we are and where we go. Mohammadpour A; Derakhshan M; Darabi H; Hedayat P; Momeni M J Cell Physiol; 2019 Apr; 234(4):3307-3320. PubMed ID: 30362507 [TBL] [Abstract][Full Text] [Related]
34. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas. Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492 [TBL] [Abstract][Full Text] [Related]
35. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces. Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222 [TBL] [Abstract][Full Text] [Related]
36. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. Ahadi A IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236 [TBL] [Abstract][Full Text] [Related]
37. A step-by-step microRNA guide to cancer development and metastasis. Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis. Tomasetti M; Amati M; Santarelli L; Neuzil J Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213336 [TBL] [Abstract][Full Text] [Related]
39. Signatures of microRNAs and selected microRNA target genes in human melanoma. Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294 [TBL] [Abstract][Full Text] [Related]